Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirin.

Autor: Cont, Fabio, Vukotic, Ranka, Lorenzini, Stefania, Riili, Anna, Cursaro, Carmela, Scuteri, Alessandra, Loggi, Elisabetta, Galli, Silvia, Furlini, Giuliano, Bernardi, Mauro, Andreone, Pietro

Publikováno v: Annals of Hepatology: Official Journal of the Mexican Association of Hepatology; Mar/Apr2014, Vol. 13 Issue 2, p196-203, 8p, 1 Diagram, 3 Charts, 1 Graph